What VCs Look for in Psychedelic Companies
Business Trip
00:00
Introduction
Matthias Zurbinsky moderates a panel at the Psychedelics Therapeutic and Drug Development Conference in San Francisco. He talks with three VCs about what it really takes for a traditional biotech VC to fund a psychedelic company. The idea is that we need larger sources of funding, as well as people who are very experienced both on translational science and bringing a drug to the clinic.
Transcript
Play full episode
